May 15, 1998
Note: The guidelines have been revised; for the updated guidelines in PDF format, click here.
Risk for Occupational Transmission of HIV to HCWs
HIV Seroconversion in HCWs
Rationale for PEP
Exposure Report
Exposure Management
HIV PEP
Follow-up of HCWs Exposed to HIV
First-Line Drugs for HIV Postexposure Prophylaxis (PEP)
Antiretroviral Drugs Used for Treatment of HIV Infection That May Be Considered for PEP in Special Circumstances
Next
Follow Us: Facebook, Twitter, RSS